HealthyWay (HKSE:02587) Other Stockholders Equity: HK$314 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02587 HealthyWay Inc HKSE:02587
13 GF Score
Price HK$1.60
! 2 Warning Signs
View Full Analysis

What is HealthyWay Other Stockholders Equity?

HealthyWay HKSE:02587 -4.19% 13 Other Stockholders Equity is HK$314 Mil as of Jun. 2026. GuruFocus rates HKSE:02587 with a GF Score™ of 13/100. The stock has 2 warning signs investors should review.

HealthyWay's Other Stockholders Equity for the quarter that ended in Jun. 2026 was HK$314 Mil.

HealthyWay's quarterly Other Stockholders Equity increased from Jun. 2025 (HK$2,817 Mil) to Dec. 2025 (HK$2,844 Mil) but then declined from Dec. 2025 (HK$2,844 Mil) to Jun. 2026 (HK$314 Mil).

HealthyWay's annual Other Stockholders Equity increased from Dec. 2023 (HK$643 Mil) to Dec. 2024 (HK$2,750 Mil) and increased from Dec. 2024 (HK$2,750 Mil) to Dec. 2025 (HK$2,844 Mil).

HealthyWay Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for HealthyWay's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HealthyWay Other Stockholders Equity Chart

HealthyWay Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
700.29 655.33 643.38 2,750.29 2,844.13

HealthyWay Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only 633.75 2,750.29 2,817.14 2,844.13 313.72
HKSE:02587
13GF Score
HealthyWay Inc HKSE:02587
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HealthyWay Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of HK$314 Mil mean?
HealthyWay (HKSE:02587) has a Other Stockholders Equity of HK$314 Mil as of Jun. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on HealthyWay and its competitors.
Is HealthyWay's Other Stockholders Equity too high?
HealthyWay's current Other Stockholders Equity is HK$314 Mil. Overall, HealthyWay has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does HealthyWay's Other Stockholders Equity compare to VEEV and BTSG?
HealthyWay's Other Stockholders Equity of HK$314 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Providers & Services company?
A good Other Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on HealthyWay and its competitors. HealthyWay's current Other Stockholders Equity is HK$314 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthyWay stock overvalued right now?
HealthyWay (HKSE:02587) has a current Other Stockholders Equity of HK$314 Mil. The current Other Stockholders Equity is HK$314 Mil. HealthyWay's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For HealthyWay (HKSE:02587), the current Other Stockholders Equity is HK$314 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HealthyWay Business Description

Address 89 Software Avenue, 22nd Floor, No. 3 Building, F Zone, Fuzhou Software Park, Gulou District, Fujian, Fuzhou, CHN
HealthyWay Inc operates a digital health and medical service platform in China. It has two main business segments: health and medical services; and corporate and digital marketing services. The health and medical services enable It to build an extensive connection between the supply and demand sides of the digital health and wellness market. The corporate services (especially content services) can benefit from its nationwide physician network, because it can develop corporate services that cover a wider range of medical specialties. The company generates the majority of its revenue from the corporate and digital marketing services.
13GF Score

Get the complete analysis for HKSE:02587

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.60
Price